Stay updated on Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.

Latest updates to the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page
- Check2 days agoChange DetectedRemoves the sponsor attribution, a document descriptor, and a navigation header in the Study Documents area. This reduces visible context and access to study materials for the page.SummaryDifference0.2%

- Check9 days agoChange DetectedThe page footer now shows Revision: v3.6.4, indicating a newer site build; Revision: v3.6.3 is removed from the display.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows Revision: v3.6.3 instead of v3.6.2, indicating a small maintenance/version update to the page's metadata. This does not modify the substantive study content.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page now displays the site revision as v3.6.2, indicating a deployment update. This change does not modify the displayed study details.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now indicates that recruitment has ended and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading formatting was standardized and the revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check59 days agoChange DetectedThe revision label on the page changes from v3.5.4 to v3.5.5. This signals a new build/update of the page content and related assets.SummaryDifference0.1%

Stay in the know with updates to Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.